DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yockman, JW | - |
dc.contributor.author | Kim, WJ | - |
dc.contributor.author | Chang, CW | - |
dc.contributor.author | Kim, SW | - |
dc.date.accessioned | 2016-04-01T08:50:53Z | - |
dc.date.available | 2016-04-01T08:50:53Z | - |
dc.date.created | 2009-09-30 | - |
dc.date.issued | 2007-10 | - |
dc.identifier.issn | 0969-7128 | - |
dc.identifier.other | 2007-OAK-0000016692 | - |
dc.identifier.uri | https://oasis.postech.ac.kr/handle/2014.oak/28900 | - |
dc.description.abstract | Treatments for renal cell carcinoma, while promising, are still limited by toxicity and cost. In the hopes of finding a novel compound or combination, we developed a plasmid containing the genes for interleukin-2 (IL-2) and soluble vascular endothelial growth factor receptor 2 (msFlk1). The plasmid, p2CMVIL2/msFlk1, demonstrated similar in vitro transgene expression of IL-2 or msFlk1 compared to their single-agent counterparts. Subcutaneous tumor growth was significantly inhibited in the p2CMVIL2/msFlk1 group when delivered locally by the non-viral water soluble polymer, WSLP and exhibited a 50% increase in survival over glucose and single-agent controls. In vivo experimentation demonstrated that WSLP/msFlk1 decreased micro-vessel density in pCMVmsFlk1 and p2CMVIL2/msFlk1 treated groups. Furthermore, tumor-infiltrating lymphocytes expressing CD45RO and CD68 were increased within the tumor microenvironment upon p2CMVIL2/msFlk1 treatment. To determine the effects of p2CMVIL2/msFlk1 in an experimental RENCA lung metastases model, therapeutic DNA was delivered systemically following complexation with the angiogenic endothelial-targeting polymer PEI-g-PEG-RGD. The p2CMVIL2/msFlk1 treatment significantly reduced metastases by 56% over single-agent therapy and increased survival proportions by 50% over all groups. Our work clearly demonstrates that non-viral delivery of p2CMVIL2/msFlk1 can inhibit RENCA growth in a synergistic manner and may represent a new treatment for renal carcinoma. | - |
dc.description.statementofresponsibility | X | - |
dc.language | English | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.relation.isPartOf | GENE THERAPY | - |
dc.subject | RECOMBINANT INTERLEUKIN-2 | - |
dc.subject | ANTITUMOR-ACTIVITY | - |
dc.subject | GENE DELIVERY | - |
dc.subject | T-CELLS | - |
dc.subject | ENDOSTATIN | - |
dc.subject | THERAPY | - |
dc.subject | LYMPHOCYTES | - |
dc.subject | COMBINATION | - |
dc.subject | EXPRESSION | - |
dc.subject | MURINE | - |
dc.title | NON-VIRAL DELIVERY OF INTERLEUKIN-2 AND SOLUBLE FLK-1 INHIBITS METASTATIC AND PRIMARY TUMOR GROWTH IN RENAL CELL CARCINOMA | - |
dc.type | Article | - |
dc.contributor.college | 화학과 | - |
dc.identifier.doi | 10.1038/SJ.GT.330299 | - |
dc.author.google | Yockman, JW | - |
dc.author.google | Kim, WJ | - |
dc.author.google | Chang, CW | - |
dc.author.google | Kim, SW | - |
dc.relation.volume | 14 | - |
dc.relation.issue | 19 | - |
dc.relation.startpage | 1399 | - |
dc.relation.lastpage | 1405 | - |
dc.contributor.id | 10135304 | - |
dc.relation.journal | GENE THERAPY | - |
dc.relation.index | SCI급, SCOPUS 등재논문 | - |
dc.relation.sci | SCI | - |
dc.collections.name | Journal Papers | - |
dc.type.rims | ART | - |
dc.identifier.bibliographicCitation | GENE THERAPY, v.14, no.19, pp.1399 - 1405 | - |
dc.identifier.wosid | 000249525400004 | - |
dc.date.tcdate | 2019-01-01 | - |
dc.citation.endPage | 1405 | - |
dc.citation.number | 19 | - |
dc.citation.startPage | 1399 | - |
dc.citation.title | GENE THERAPY | - |
dc.citation.volume | 14 | - |
dc.contributor.affiliatedAuthor | Kim, WJ | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.wostc | 9 | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | RECOMBINANT INTERLEUKIN-2 | - |
dc.subject.keywordPlus | ANTITUMOR-ACTIVITY | - |
dc.subject.keywordPlus | GENE DELIVERY | - |
dc.subject.keywordPlus | T-CELLS | - |
dc.subject.keywordPlus | ENDOSTATIN | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | LYMPHOCYTES | - |
dc.subject.keywordPlus | COMBINATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MURINE | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Genetics & Heredity | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
library@postech.ac.kr Tel: 054-279-2548
Copyrights © by 2017 Pohang University of Science ad Technology All right reserved.